Daily Clinical Briefing · Educational reading for healthcare professionals
Atypical symptoms and absent risk factors do not reliably exclude myocardial infarction.
Indigestion-like chest pain is not reassuring when myocardial infarction remains a plausible explanation.
Chest pain does not become reassuring simply because it sounds like indigestion, the patient has no familiar cardiovascular risk factors or the clinician thinks acute coronary syndrome is unlikely.
The important question is whether there is a convincing explanation for the symptoms. If there is not, and myocardial infarction remains plausible, symptom labels are a poor reason to avoid troponin testing.
The numbers behind this need careful handling. In a cohort of more than 800 patients already selected by clinicians for myocardial infarction investigation, the baseline probability was 19%. Heavy or crushing pain shifted that to 22%. So did indigestion-like pain. The familiar description of “typical” pain offered surprisingly little separation from a symptom many clinicians might instinctively find reassuring.
Some associated findings performed better. Vomiting was associated with a 41% probability of myocardial infarction and sweating observed during assessment with 59%, considered separately. Observed sweating matters here: it should not be treated as equivalent to a patient reporting that they sweated during an earlier episode.
But these figures come from a population already considered to need investigation. They are not probabilities to apply indiscriminately to everyone attending with chest pain.
“Typical” and “atypical” are weak gatekeepers too. One study found no difference in acute coronary syndrome probability between those symptom groups; another found typical symptoms had only 51% sensitivity for myocardial infarction. Restricting testing to what sounds typical would therefore leave roughly half of myocardial infarctions outside that group.
Risk factors do not rescue the decision. In two investigated cohorts, patients with none of five recorded cardiovascular risk factors still had myocardial infarction probabilities of 12.2% and 10%. Clinical judgement adds useful information, but remains fallible: one multicentre study found myocardial infarction in 5% of patients initially judged “definitely not” to have acute coronary syndrome.
The response is not to order troponin for every episode of chest pain. Take the history properly, understand why the patient has attended and look for a clear explanation. When the symptoms remain unexplained and myocardial infarction is still plausible, mild, transient or indigestion-like pain should not be used to avoid testing.
Interstitial lung disease treatment increasingly depends on inflammatory or fibrotic behaviour and evidence of progression. Antifibrotics slow rather than cure disease, while symptom control, representative trial recruitment, equitable diagnostic access and palliative care remain important alongside disease-modifying treatment.
Cardiac output monitoring should complement rather than replace bedside assessment of perfusion. Thermodilution, pulse contour analysis, Doppler and echocardiography each have assumptions and limitations, while normal blood pressure or a reassuring displayed value can coexist with inadequate flow.
Child neurology training raises separate questions about adult neurology exposure and overall programme duration. A deliberately diverse task force is gathering senior and junior views for an anticipated accreditation review, with clarification of disagreements potentially more useful than forced consensus.
Chest-pain character, cardiovascular risk-factor counts and clinical judgement cannot reliably exclude myocardial infarction on their own. Detailed history should seek a convincing explanation, with troponin testing when symptoms remain unexplained and myocardial infarction is still plausible.
When assessing chest pain, avoid using “typical”, “atypical” or a cardiovascular risk-factor count as the sole gatekeeper for troponin testing. Record vomiting and distinguish sweating observed during assessment from sweating reported earlier. If the history does not provide a clear explanation and myocardial infarction remains plausible, investigate rather than relying on a reassuring symptom label.
A patient presents with mild chest discomfort described as indigestion and reports no hypertension, hyperlipidaemia, smoking, diabetes or family history. The history does not reveal a convincing alternative explanation and myocardial infarction remains plausible. Should the symptom description and absence of these risk factors prevent troponin testing?
No. Indigestion-like pain and absence of recorded cardiovascular risk factors do not reliably exclude myocardial infarction. Troponin testing remains appropriate when symptoms are unexplained and myocardial infarction is plausible.
A chest-pain service proposes testing troponin only when symptoms are classified as typical. A study reports that typical symptoms have 51% sensitivity for myocardial infarction. Approximately what proportion of myocardial infarctions would fall outside that symptom-defined testing group?
Approximately 49%. A sensitivity of 51% means that restricting testing to patients with typical symptoms would leave roughly half of myocardial infarctions outside the selected group.
A critically ill patient has a normal blood pressure but cold peripheries, poor urine output and other evidence of impaired perfusion. Does the normal pressure establish that cardiac output is adequate?
No. Mean arterial pressure reflects both cardiac output and systemic vascular resistance, so normal pressure can coexist with inadequate flow. Bedside perfusion, urine output, lactate and other haemodynamic information should be assessed rather than relying on pressure alone.
Daily Clinical Briefings are prepared using ChatGPT Pro from the show notes and educational output for that day’s episodes. Iain Beardsell then checks the briefing for accuracy.
This describes the current briefing process. Item-specific review dates are shown only where documented. The original podcasts remain the sources; MedPod’s briefing is additional educational material.
Read about MedPod’s editorial approach
Report an error or source concern — please include the article title and link, without patient-identifying information.
.svg)